Enhanced Sensitivity to Chemotherapy in Esophageal Cancer through Inhibition of NF-κB
- 31 May 2006
- journal article
- Published by Elsevier BV in Journal of Surgical Research
- Vol. 132 (1), 112-120
- https://doi.org/10.1016/j.jss.2005.10.005
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Inhibition of NF-Kappa B augments sensitivity to 5-Fluorouracil/Folinic acid in colon cancer1Journal of Surgical Research, 2004
- Inducible nuclear factor-κB activation contributes to chemotherapy resistance in gastric cancer1Journal of the American College of Surgeons, 2004
- Survival-signaling pathway as a promising target for cancer chemotherapyCancer Chemotherapy and Pharmacology, 2003
- NF-κB in cancer: a marked targetSeminars in Cancer Biology, 2003
- Disulfiram‐mediated inhibition of NF‐κB activity enhances cytotoxicity of 5‐fluorouracil in human colorectal cancer cell linesInternational Journal of Cancer, 2003
- Cancer statistics, 2000CA: A Cancer Journal for Clinicians, 2000
- Activators and target genes of Rel/NF-κB transcription factorsOncogene, 1999
- Resistance to 5-FluorouracilGeneral Pharmacology: The Vascular System, 1998
- Nuclear factor – κB-dependent regulation of p53 gene expression induced by daunomycin genotoxic drugOncogene, 1998
- Intermittent continuous infusion of 5-fluorouracil and low dose oral leucovorin in patients with gastrointestinal cancer: Relationship between plasma concentrations and clinical parametersEuropean Journal of Cancer, 1995